➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Merck
McKinsey
Moodys
Harvard Business School
Mallinckrodt
Medtronic

Last Updated: April 12, 2021

DrugPatentWatch Database Preview

Losartan potassium - Generic Drug Details

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

What are the generic sources for losartan potassium and what is the scope of patent protection?

Losartan potassium is the generic ingredient in two branded drugs marketed by Organon, Alembic Pharms Ltd, Apotex Corp, Aurobindo Pharma, Cadista Pharms, Hetero Labs Ltd V, Hikma, Hisun Pharm Hangzhou, Ipca Labs Ltd, Lupin Ltd, Macleods Pharms Ltd, Micro Labs, Mylan, Prinston Inc, Sandoz, Strides Pharma, Teva, Torrent Pharms, Unichem, Upsher Smith Labs, Watson Labs, and Zydus Pharms Usa Inc, and is included in twenty-two NDAs. Additional information is available in the individual branded drug profile pages.

There are thirty-nine drug master file entries for losartan potassium. Fifty-one suppliers are listed for this compound.

Drug Prices for losartan potassium

See drug prices for losartan potassium

Drug Sales Revenue Trends for losartan potassium

See drug sales revenues for losartan potassium

Recent Clinical Trials for losartan potassium

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Anna Stanhewicz, PhDEarly Phase 1
Oregon Health and Science UniversityPhase 2
OHSU Knight Cancer InstitutePhase 2

See all losartan potassium clinical trials

Pharmacology for losartan potassium
Medical Subject Heading (MeSH) Categories for losartan potassium
Paragraph IV (Patent) Challenges for LOSARTAN POTASSIUM
Tradename Dosage Ingredient NDA Submissiondate
COZAAR TABLET;ORAL losartan potassium 020386

US Patents and Regulatory Information for losartan potassium

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Upsher Smith Labs LOSARTAN POTASSIUM losartan potassium TABLET;ORAL 090544-003 Oct 6, 2010 AB RX No No   Start Trial   Start Trial   Start Trial
Apotex Corp LOSARTAN POTASSIUM losartan potassium TABLET;ORAL 090790-001 Oct 6, 2010 DISCN No No   Start Trial   Start Trial   Start Trial
Torrent Pharms LOSARTAN POTASSIUM losartan potassium TABLET;ORAL 090467-002 Oct 6, 2010 DISCN No No   Start Trial   Start Trial   Start Trial
Strides Pharma LOSARTAN POTASSIUM losartan potassium TABLET;ORAL 090382-003 Oct 6, 2010 AB RX No No   Start Trial   Start Trial   Start Trial
Zydus Pharms Usa Inc LOSARTAN POTASSIUM losartan potassium TABLET;ORAL 078243-003 Oct 6, 2010 AB RX No No   Start Trial   Start Trial   Start Trial
Hikma LOSARTAN POTASSIUM losartan potassium TABLET;ORAL 077459-003 Oct 6, 2010 DISCN No No   Start Trial   Start Trial   Start Trial
Micro Labs LOSARTAN POTASSIUM losartan potassium TABLET;ORAL 091541-003 Sep 24, 2012 AB RX No No   Start Trial   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Expired US Patents for losartan potassium

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Organon COZAAR losartan potassium TABLET;ORAL 020386-001 Apr 14, 1995   Start Trial   Start Trial
Organon COZAAR losartan potassium TABLET;ORAL 020386-003 Oct 13, 1998   Start Trial   Start Trial
Organon COZAAR losartan potassium TABLET;ORAL 020386-002 Apr 14, 1995   Start Trial   Start Trial
Organon COZAAR losartan potassium TABLET;ORAL 020386-001 Apr 14, 1995   Start Trial   Start Trial
Organon COZAAR losartan potassium TABLET;ORAL 020386-003 Oct 13, 1998   Start Trial   Start Trial
Organon COZAAR losartan potassium TABLET;ORAL 020386-002 Apr 14, 1995   Start Trial   Start Trial
Organon COZAAR losartan potassium TABLET;ORAL 020386-003 Oct 13, 1998   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >Patent No. >Patent Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Harvard Business School
McKinsey
Merck
Dow
Johnson and Johnson
Baxter

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.